JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M507800200 on August 15, 2005

J. Biol. Chem., Vol. 280, Issue 42, 35469-35476, October 21, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/42/35469    most recent
M507800200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holm, M. M.
Right arrow Articles by Egebjerg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holm, M. M.
Right arrow Articles by Egebjerg, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Binding Site Tyrosine Shapes Desensitization Kinetics and Agonist Potency at GluR2

A MUTAGENIC, KINETIC, AND CRYSTALLOGRAPHIC STUDY*{boxs}

Mai Marie Holm{ddagger}§1, Peter Naur¶, Bente Vestergaard¶, Matthew T. Geballe||, Michael Gajhede¶, Jette S. Kastrup¶, Stephen F. Traynelis§, and Jan Egebjerg{ddagger}

From the {ddagger}Department of Molecular Biology, C. F. Møllers Allé Bldg. 130, University of Aarhus, DK-8000 Aarhus, Denmark, §Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, Biostructural Research, Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen, Denmark, and ||Department of Chemistry, Emory University, Atlanta, Georgia 30322

Binding of an agonist to the 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)-propionic acid (AMPA) receptor family of the glutamate receptors (GluRs) results in rapid activation of an ion channel. Continuous application results in a non-desensitizing response for agonists like kainate, whereas most other agonists, such as the endogenous agonist (S)-glutamate, induce desensitization. We demonstrate that a highly conserved tyrosine, forming a wedge between the agonist and the N-terminal part of the bi-lobed ligand-binding site, plays a key role in the receptor kinetics as well as agonist potency and selectivity. The AMPA receptor GluR2, with mutations in Tyr-450, were expressed in Xenopus laevis oocytes and characterized in a two-electrode voltage clamp setup. The mutation GluR2(Y450A) renders the receptor highly kainate selective, and rapid application of kainate to outside-out patches induced strongly desensitizing currents. When Tyr-450 was substituted with the larger tryptophan, the (S)-glutamate desensitization is attenuated with a 10-fold increase in steady-state/peak currents (19% compared with 1.9% at the wild type). Furthermore, the tryptophan mutant was introduced into the GluR2-S1S2J ligand binding core construct and co-crystallized with kainate, and the 2.1-Å x-ray structure revealed a slightly more closed ligand binding core as compared with the wild-type complex. Through genetic manipulations combined with structural and electrophysiological analysis, we report that mutations in position 450 invert the potency of two central agonists while concurrently strongly shaping the agonist efficacy and the desensitization kinetics of the AMPA receptor GluR2.


Received for publication, July 18, 2005 , and in revised form, August 15, 2005.

The atomic coordinates and structure factors (code 2ANJ (GluR2-S1S2J(Y450W)-kainate)) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* The work was supported by the University of Aarhus (to M. M. H.), NeuroScience PharmaBiotec (to M. M. H.), The Lundbeck Foundation (to B. V., M. G., and J. S. K.), DANSYNC (Danish Centre for Synchrotron Based Research) (to P. N., B. V., M. G., and J. S. K.), The Danish Medical Research Council (to P. N., B. V., M. G., J. S. K., and J. E.), The Drug Research Academy (to P. N.), and NINDS, National Institutes of Health (to S. F. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains supplemental Table I.

1 To whom correspondence should be addressed: Institute of Physiology and Biophysics, Bldg. 160, University of Aarhus, DK-8000 Aarhus C, Denmark. Tel.: 45-8942-2800; Fax: 45-8612-9065; E-mail: mmh{at}fi.au.dk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.